TW200538154A - Combination of organic compounds - Google Patents

Combination of organic compounds Download PDF

Info

Publication number
TW200538154A
TW200538154A TW094104477A TW94104477A TW200538154A TW 200538154 A TW200538154 A TW 200538154A TW 094104477 A TW094104477 A TW 094104477A TW 94104477 A TW94104477 A TW 94104477A TW 200538154 A TW200538154 A TW 200538154A
Authority
TW
Taiwan
Prior art keywords
pharmaceutically acceptable
combination
acceptable salt
hypertension
disease
Prior art date
Application number
TW094104477A
Other languages
English (en)
Chinese (zh)
Inventor
Suraj Shivappa Shetty
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200538154A publication Critical patent/TW200538154A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
TW094104477A 2004-02-17 2005-02-16 Combination of organic compounds TW200538154A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54523904P 2004-02-17 2004-02-17

Publications (1)

Publication Number Publication Date
TW200538154A true TW200538154A (en) 2005-12-01

Family

ID=34860518

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094104477A TW200538154A (en) 2004-02-17 2005-02-16 Combination of organic compounds

Country Status (3)

Country Link
AR (1) AR047880A1 (es)
TW (1) TW200538154A (es)
WO (1) WO2005077418A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080161321A1 (en) * 2004-03-17 2008-07-03 David Louis Feldman Use of Renin Inhibitors in Therapy
GB0612540D0 (en) 2006-06-23 2006-08-02 Novartis Ag Galenical formulations of organic compounds
RU2009126741A (ru) * 2006-12-15 2011-01-20 Новартис АГ (CH) Ингибиторы ренина, предназначенные для профилактики и лечения гипертензии у пациентов, страдающих от ожирения
EP2062874B1 (en) 2007-11-20 2014-12-17 KRKA, tovarna zdravil, d.d., Novo mesto Process and intermediates for the preparation of aliskiren
WO2009087116A1 (en) * 2008-01-11 2009-07-16 Novartis Ag Use of spp100 for the treatment of acute mi
EP2189442B1 (en) 2008-11-20 2014-10-01 Krka Tovarna Zdravil, D.D., Novo Mesto Process and intermediates for the preparation of aliskiren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3517820A1 (de) * 1985-05-17 1986-11-20 Röhm Pharma GmbH, 6108 Weiterstadt Pharmazeutische praeparate mit antihypertensiver und kardioprotektiver wirkung
RU2316318C2 (ru) * 2002-05-17 2008-02-10 Новартис Аг Фармацевтическая композиция, включающая ингибитор ренина, блокатор кальциевых каналов и диуретик

Also Published As

Publication number Publication date
WO2005077418A1 (en) 2005-08-25
AR047880A1 (es) 2006-03-01

Similar Documents

Publication Publication Date Title
EP1602370B1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
JP4846063B2 (ja) 選択的ｓ１ｐ１レセプターアゴニストの投与法
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
TW200538154A (en) Combination of organic compounds
CN105682653A (zh) 新型2，4-二硝基苯酚制剂和使用其的方法
JP4569106B2 (ja) 臓器線維化抑制剤
TW201722413A (zh) 用於治療肥胖及肥胖相關病症之包含卡格列淨（ｃａｎａｇｌｉｆｌｏｚｉｎ）與芬特明（ｐｈｅｎｔｅｒｍｉｎｅ）的協同治療
AU2022353124A1 (en) Combination comprising atogepant for treating migraine
US9375411B2 (en) Uses and methods for the treatment of liver diseases or conditions
US20090036432A1 (en) Combinations of AT1-antagonists, amiloride or triamterine, and a diuretic
JP2005522466A (ja) アルドステロン受容体アンタゴニスト、およびニコチン酸またはニコチン酸誘導体の組合わせ
JP2009533413A (ja) 鎮痛剤およびビタミンを含む医薬組成物
CH675684A5 (es)
US9610285B2 (en) Compositions for controlling food intake and uses therefor
JP4974255B2 (ja) アンジオテンシンｉｉ受容体拮抗剤の配合剤
KR20220128984A (ko) sGC 자극제를 사용한 당뇨병성 신장병증의 치료
WO2024049926A1 (en) Dosage regimens of estrogen receptor degraders
EA046106B1 (ru) ПРИМЕНЕНИЕ АНТАГОНИСТА mGluR5 ДЛЯ ЛЕЧЕНИЯ ТОЛЕРАНТНОСТИ К ОПИОИДНЫМ АНАЛЬГЕТИКАМ
WO2022144590A1 (en) Celecoxib for treating pain
KR20100102631A (ko) 메트포르민 및 ｍｐｔ 저해제의 배합물
TW201304775A (zh) 使用依普羅沙坦與氨氯地平治療高血壓的組成物和方法
JP2010222347A (ja) Ｐｄｅ５阻害剤及びカルニチンを含有する医薬組成物
JPS59184124A (ja) 腎不全、糖尿病及び糖尿病性腎症におけるエネルギー代謝改善剤
MXPA06004933A (es) Combinaciones de antagonistas de at1, amiloride o triamterine y un diuretico
JP2005523302A (ja) アルドステロン受容体アンタゴニストおよびフィブリン酸誘導体の併用